Georgia Regents University MedCollege of GA Cancer Ctr 2 — Augusta, Georgia

Georgia Regents University MedCollege of GA Cancer Ctr 2 is a clinical research site located in Augusta, Georgia, United States 30912.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Georgia Regents University MedCollege of GA Cancer Ctr 2 has participated in 2 clinical trials.

Therapeutic areas: Relapsed and Bortezomib Refractory Multiple Myeloma, Refractory Multiple Myeloma, Multiple Myeloma in Relapse.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgia Regents University MedCollege of GA Cancer Ctr 2?

Georgia Regents University MedCollege of GA Cancer Ctr 2 has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgia Regents University MedCollege of GA Cancer Ctr 2 conducted?

Georgia Regents University MedCollege of GA Cancer Ctr 2 has 2 clinical trials on record. Their work covers Relapsed and Bortezomib Refractory Multiple Myeloma, Refractory Multiple Myeloma, Multiple Myeloma in Relapse.

Is Georgia Regents University MedCollege of GA Cancer Ctr 2 accredited by Crixeo Health?

Georgia Regents University MedCollege of GA Cancer Ctr 2 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgia Regents University MedCollege of GA Cancer Ctr 2?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.